Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsSoutheast Asia's (SEA) healthcare financing systems have been managed well thus far but there remain gaps with the unsustainable pace in which healthcare needs and costs are growing. In the last decade, SEA has experienced rapid changes, driven by aging populations and increasing life expectancy. Coupled with shifting disease burden towards chronic non-communicable disease, the demand for healthcare has increased substantially.
Yet this rise in demand has not been proportionately matched by government spending on health with concerns over straining public funds. Expenditure remains at an average of 4-5% of total GDP across Southeast Asia, below the global average of 6-7%, and well below the OECD markets average of ~13%. Will the current system be sufficient to manage the growing healthcare demands and overcome the challenges of healthcare financing within the region?
This whitepaper will highlight the obstacles SEA nations face in their past attempts for healthcare financing reform, successful case studies of Europe and North America as well as approaches SEA nations can adopt to overcome this long-standing problem.
To find out more about healthcare financing in Southeast Asia, please contact us.
A global study of new solutions disrupting healthcare financing
A global study of new financing solutions for rare diseases
A global study of the health financing context, challenges and opportunities for rare diseases in LMICs
In a global landscape study, 106 innovative funding solutions were identified with collaboration and knowledge sharing noted as the key success factors.